Cocrystal Pharma, Inc.
COCP
$1.55
$0.0050.33%
NASDAQ
| 06/30/2025 | 03/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -17.50% | -33.24% | |||
| Gross Profit | 17.50% | 33.24% | |||
| SG&A Expenses | 0.51% | -17.77% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -9.95% | -27.52% | |||
| Operating Income | 9.95% | 27.52% | |||
| Income Before Tax | 10.69% | 29.55% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 10.69% | 29.55% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 10.69% | 29.55% | |||
| EBIT | 9.95% | 27.52% | |||
| EBITDA | 9.89% | 27.67% | |||
| EPS Basic | 10.70% | 29.53% | |||
| Normalized Basic EPS | 10.75% | 29.51% | |||
| EPS Diluted | 10.70% | 29.53% | |||
| Normalized Diluted EPS | 10.75% | 29.51% | |||
| Average Basic Shares Outstanding | 0.00% | 0.00% | |||
| Average Diluted Shares Outstanding | 0.00% | 0.00% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||